Journal of Modern Oncology
ISSN 1815-1434 (Print)
ISSN 1815-1442 (Online)
Menu
Archives
Home
About the Journal
Editorial Policies
Author Guidelines
About the Journal
Issues
Search
Current
Archives
Contact
Editorial board
OmniDoctor
All Journals
User
Username
Password
Remember me
Forgot password?
Register
Search
Search
Search Scope
All
Authors
Title
Abstract
Index terms
Full Text
Browse
By Issue
By Author
By Title
Other Journals
×
User
Username
Password
Remember me
Forgot password?
Register
Search
Search
Search Scope
All
Authors
Title
Abstract
Index terms
Full Text
Browse
By Issue
By Author
By Title
Other Journals
Home
>
Search
>
Author Details
Author Details
Федянин, Михаил Юрьевич
Issue
Section
Title
File
Vol 17, No 3 (2015)
Articles
Choice of anti-angiogenic agents in second-line treatment in patients with metastatic colon cancer: bevacizumab, aflibercept, ramucirumab (a literature review)
Vol 19, No 3 (2017)
Articles
BCD-100 - first russian PD-1 inhibitor
(Rus)
Vol 19, No 3 (2017)
Articles
Regorafenib: from clinical research to clinical practice
(Rus)
Vol 21, No 3 (2019)
Articles
Effect of starting dose of regorafenib on overall survival of patients with metastatic colorectal cancer: a systematic review and meta-analysis
Vol 23, No 1 (2021)
CLINICAL ONCOLOGY
Comparison of the efficacy of first-line therapy with different generations of EGFR tyrosine kinase inhibitors in patients with advanced EGFR-associated non-small cell lung cancer: a network meta-analysis of overall survival data
(Rus)
Vol 23, No 4 (2021)
CLINICAL ONCOLOGY
Multicenter prospective observational post-approval study of safety and efficacy of bevacizumab (Avegra®, BIOCAD) in patients with metastatic colorectal cancer in real world practice: APOLLON-11 and SOYUZ-APOLLON
(Rus)
Vol 25, No 1 (2023)
CLINICAL ONCOLOGY
The possibilities of therapy of patients with metastatic colorectal cancer with
BRAF
V600E mutation. Clinical cases
(Rus)
Vol 24, No 4 (2022)
CLINICAL ONCOLOGY
Real-world efficacy of the first line therapy with prolgolimab in patients with metastatic melanoma: interim results of the FORA (FOrteca Real practice Assessment) observational study
(Rus)
Vol 25, No 3 (2023)
CLINICAL ONCOLOGY
Resolution of the advisory board on the topic: “The place of entrectinib in the treatment of adult patients with NTRK-fusion positive solid tumors”
(Rus)
Vol 26, No 1 (2024)
Articles
Venous thrombosis during systemic antitumor therapy: risks, prognosis, treatment
(Rus)
Vol 26, No 1 (2024)
Articles
Final data on the efficacy of the FORA study (FOrteca Real practice Assessment): a multicenter prospective observational study on the real-world efficacy of prolgolimab in patients with metastatic melanoma in Russia
(Rus)
This website uses cookies
You consent to our cookies if you continue to use our website.
About Cookies
TOP